|
US8431155B1
|
|
Bromocriptine formulations
|
|
US2011195970A1
|
|
Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
|
|
US2011195971A1
|
|
Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
|
|
US2009143390A1
|
|
Parenteral formulations of dopamine agonists
|
|
US2008293735A1
|
|
Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
|
|
US2008200453A1
|
|
Methods of treating metabolic syndrome using dopamine receptor agonists
|
|
US2005215558A1
|
|
Methods of identifying responders to dopamine agonist therapy
|
